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Abstract 
A 55-year-old male with idiopathic Parkinson’s disease developed three behavioral changes 
under combination therapy with selegiline, cabergoline and levodopa. Co-existent behaviors 
included severe pathological gambling, punding and novel skills in writing poetry (published 
poetry books). Brain [
18F]fluorodopa PET imaging showed decreased tracer uptake in the 
striatum contralateral to the predominant motor symptoms, consistent with the clinical 
diagnosis of Parkinson’s disease. Uptake in the ventral striatum was markedly high. Brain 
MRI before and after behavioral changes showed no pathological findings. The patient was 
diagnosed as having Parkinson’s disease together with DSM-IV criteria-fulfilling pathological 
gambling and punding-like stereotyped behavior. There are no established criteria for the 
classification of emerged artistic creativity, although there are descriptions of the 
phenomenon in the literature. Inspired by the case, we conducted a preliminary survey – 
including 290 patients with Parkinson’s disease – exploring the possible relationship 
between creativity and impulsive-compulsive behaviors. The case, supported by the results 
of the survey, adds to the cumulative evidence of the association between dopaminergic 
medication and enhanced creativity, and suggests a possible linkage between increased 
artistic creativity and impulsive-compulsive behaviors in Parkinson’s disease. Furthermore, it 
could be speculated that the high mesolimbic dopamine function might relate to the 
behavioral changes observed in this patient, and is suggestive of the overlapping 
neurobiological mechanisms of compulsive behaviors and artistic creativity. 
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Introduction 
Over the past decade, it has become evident that Parkinson’s disease and dopamine 
replacement therapy are associated with the increased frequency of impulse control 
disorders, such as pathological gambling, compulsive shopping, binge eating and 
hypersexuality [1]. Other repetitive behaviors, such as punding, walkabout and 
hobbyism, are also common in Parkinson’s disease patients, and multiple behavioral 
problems occur frequently [2]. Anecdotal reports of changes in artistic creativity due to 
antiparkinsonian medication have been previously reported. For instance, a 
Parkinson’s disease patient was reported to have developed novel poetic writing skills 
after starting drug treatment [3], and another patient started producing large amounts 
of artistic drawings [4]. Deep brain stimulation for Parkinson’s disease has induced 
similar effects in one patient [5], and some patients, who had already shown artistic 
talent before the diagnosis, have experienced changes in artistic style either due to 
dopaminergic medication [6] or subthalamic stimulation [7]. It has also been suggested 
that a former artistic profession in Parkinson’s disease patients could, in fact, be a risk 
factor for dopamine dysregulation syndrome, which is characterized by addiction to 
dopamine replacement therapy and stereotyped behaviors, such as punding [8]. 
Case Report 
A 55-year-old right-handed man was diagnosed with Parkinson’s disease in 2001 (onset at the age 
of 46 years). The first symptoms of the disease were rest tremor in the left hand and slight rigidity in 
the left upper extremity. Brain MRI at the time of the diagnosis showed no pathological findings. 
Antiparkinsonian medication was started at the time of the diagnosis. Medication changes over the 
course of the disease are presented in table 1. The patient had graduated from high school, 
corresponding to 12 years of formal education, and had various occupations after school including 
working as a janitor and a survey interviewer, before retiring due to motor symptoms of the disease 2 
years after the diagnosis. 
Approximately 5 years after the diagnosis, the patient gradually developed a gambling problem 
mostly for coin-operated slot machines. Before the diagnosis, the patient had no gambling problems 
and no experience in slot machine gambling. Earlier, while working as an interviewer in casinos, he 
remembered being ‘surprised’ that some people could get addicted to gambling. At the time of the 
brain PET imaging in 2010, he played more than 10 h/week on slot machines and spent more than 
1,000 €/month on electronic machine gambling. His gambling had caused him significant debts. In 
2010, pathological gambling was confirmed according to DSM-IV criteria. Maladaptive gambling 
behavior was indicated by 7 out of 10 DSM-IV items (cutoff ≥5 items) and the South Oaks Gambling 
Screen (SOGS) score was 8 out of 20 (cutoff ≥5 points). The questionnaire for impulsive-compulsive 
disorders in Parkinson’s disease (QUIP) indicated pathological gambling (5 out of 5 items, cutoff ≥2 
items), but did not indicate any other impulse control disorders. 
Together with slot machine gambling, the patient developed punding-like compulsory behavior, 
which involved picking wild berries. From the year 2006 onwards, he gradually spent more and more 
time picking berries. In 2010, the patient saw himself as being obsessed with picking wild berries 
together with the problematic gambling habit. In the autumn of 2010 alone, he picked hundreds of 
liters of lingonberries. He described going to the woods early in the morning, losing his sense of time 
and place (similar to gambling), and stayed in the woods for up to 12 h. While picking, he felt no urge 
to gamble. He started picking berries before dawn, parking his car next to the woods and using the 
headlights of his car to find berries. In 2011, due to motor fluctuations and sudden off-periods, he had 
to regularly interrupt berry picking and return to his car for levodopa dosing. 
The patient had shown no interest in arts or poetry before the diagnosis and dopamine 
replacement therapy, which was confirmed by his family and friends. Seven years after the diagnosis 
(2 years after gambling and punding started), he started writing poems. He predominantly wrote  
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early in the morning (3–7 a.m.) before taking morning medications. The themes of his poems were a 
mixture of love, disease and nature. His poetry was considered interesting by a commercial publisher, 
and his first poetry book was published 1 year later, and the second book was published in 2010. He 
showed no interest in other forms of art, such as visual arts or music. 
At the time of the PET imaging in 2010, the patient was on Hoehn and Yahr stage 2.0, and his total 
Unified Parkinson’s Disease Rating Scale (UPDRS) score was 53 [UPDRS I = 2 (out of 16), UPDRS II = 
12 (out of 52), UPDRS III = 36 (out of 108), UPDRS IV = 3 (out of 23)]. Blood count, plasma glucose, 
plasma alanine aminotransferase, plasma gamma-glutamyl transferase, fasting plasma creatinine and 
plasma carbohydrate-deficient transferring (CDT) were normal. Urine drug testing for cannabis, 
cocaine, opiates, phencyclidine, methadone, dextropropoxyphene and benzodiazepines was negative. 
Brain 1.5T MRI continued to show no pathological findings. The patient underwent a structured 
interview (SCID-I) by a consultant psychiatrist, which did not reveal any lifetime Axis-I psychiatric 
disorders or ADHD. The patient scored 10 points (out of 63) in Beck Depression Inventory, indicating 
that he did not suffer from clinically significant depression. Temperament and character inventory 
(TCI) scores were 27/40 (27 out of 40) for novelty seeking, 16/35 for harm avoidance, 20/24 for 
reward dependence, 5/8 for persistence, 36/44 for self-directedness, 34/42 for cooperativeness and 
7/33 for self-transcendence. Barratt Impulsiveness Scale (BIS-11) total score was 76, and subscores 
were 18 (range 8–32) for attentional, 23 (11–44) for motor and 35 (11–44) for non-planning 
impulsiveness. 
Brain [18F]fluorodopa-PET was performed with an ECAT EXACT HR+ scanner in 3D mode, injected 
dose 168 MBq, 90-min scanning, Patlak analysis with occipital cortex as reference, antiparkinsonian 
medications had been discontinued for 12 h prior to tracer injection, and carbidopa 150 mg had been 
given orally 1 h prior to injection, as described previously [9]. Striatal deficit in tracer uptake was 
seen especially in the putamen contralateral to the predominant symptoms of the disease, which was 
in line with the diagnosis of idiopathic Parkinson’s disease [right caudate Ki (10–3 min–1) 7.41, left 
caudate 9.35, right putamen 2.99, left putamen 4.21, right ventral striatum 10.10, left ventral striatum 
10.40, right medial orbitofrontal cortex (mOFC) 2.26, and left mOFC 2.36]. As compared to the other 
subjects of our previously reported study of Parkinson’s disease patients without known increase in 
creativity, with or without impulse control disorders, the left [whole group Ki median (range) 8.40 
(6.46–10.40) 10–3 min–1] and right ventral striatal [8.77 (7.31–10.10)], and the left caudate [7.39 
(4.87–9.35)], [18F]fluorodopa uptake of the present patient was the highest of the group (n = 19, one 
patient with self-reported increase in creativity was excluded from the analysis) [9]. 
After PET imaging, cabergoline was rapidly stopped due to pathological gambling. Soon after the 
stopping of cabergoline, pathological gambling behavior decreased without significant changes in 
punding or poetic creativity. In parallel with cabergoline discontinuation, his motor symptoms 
increased and restless legs symptoms appeared. The levodopa dose was therefore markedly increased 
in 2010 and low-dose pramipexole for restless legs syndrome was initiated (table 1). The patient felt 
that after cabergoline was stopped, his gambling was under control. Within 1 year of cabergoline 
discontinuation and levodopa dose increase in 2010, he developed significant motor fluctuations and 
is currently under consideration for deep brain stimulation. 
Survey 
Is the co-existence of the three behavioral changes coincidental in our patient? The possible 
linkage between impulsive-compulsive behaviors and artistic creativity in this patient led us to 
preliminarily investigate the phenomenon in a population of Parkinson’s disease patients. We 
performed a postal survey inquiring the issue from January to August 2011. The survey was sent to 
376 patients from our previous study [10] (patients who had indicated that they were willing to 
participate in further studies), which investigated the prevalence of impulse control disorders in 
Finnish patients with Parkinson’s disease. The survey included the QUIP together with questions 
regarding possible artistic creativity before and after the diagnosis of Parkinson’s disease. A total of 
296 (78.7%) of 376 patients returned the survey, but 6 patients were excluded because of inadequate 
data. Overall, 38.7% (n = 108 of 279) of the patients screened positive for at least one impulse control 
disorder in QUIP and 19.3% (n = 54 of 280) of the patients reported increased artistic creativity after 
the diagnosis of Parkinson’s disease. Impulse control disorders as screened with QUIP were 
significantly more frequent in patients reporting increased creativity after the diagnosis than in 
patients without creativity increase (54.7 vs. 34.6%, respectively; n = 270, χ2 = 7.31, d.f. = 1, p = 
0.007). Moreover, 33.3% (18 of the 54) of the patients with an increase in creativity subjectively  
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linked the enhanced creativity directly to dopamine replacement therapy. The prevalence of creativity 
or impulse control disorders did not vary according to the side of predominant motor symptoms or to 
the type of medication used by the patient. 
Discussion 
The clinical symptoms and findings of the patient indicated the diagnosis of 
Parkinson’s disease which was later supported by [18F]fluorodopa PET and normal 
findings in two brain MRIs, before and after the appearance of behavioral changes. The 
diagnosis of pathological gambling was confirmed according to DSM-IV criteria. To 
date, there are no generally accepted diagnostic criteria for punding, nor is it defined in 
the DSM-IV. However, the continuum of punding to hobbyism has been described as 
repetitive actions; from simple and meaningless behavioral rituals to those such as 
collecting, drawing, cleaning or categorizing, etc., overrunning physiological needs or 
social responsibilities, while patients may or may not enjoy the act or retain the insight 
of the irrationality of their behavior [11]. In this patient, the excessive berry picking 
clearly fulfilled the description above and was classified as punding, although the 
behavior was not completely stereotyped simple behavior without meaning. 
Furthermore, although the patient enjoyed berry picking, he subjectively felt that 
picking was compulsive. 
In the context of Parkinson’s disease, artistic productivity/creativity could be more 
related to the disease or the treatment than intrinsic artistic motivation. Although the 
increase in artistic creativity is multifactorial after the diagnosis of a chronic disease 
(including art produced in patient associations; the heightened interest in arts due to 
psychological factors after diagnosis and increased free time after premature 
retirement), the present data suggests that, irrespective of the cause, artistic creativity 
is associated with co-existent problems of impulse control in patients with Parkinson’s 
disease. However, it should be noted that a previous study [12] provided contradictory 
results compared to ours, which could relate to differences in power to detect 
differences (number of patients 36 and 290, respectively), or in methodology as the 
previous study included only patients with completely novel artistic productivity, 
whereas the present study also included patients with prior artistic activity. It should 
also be noted that the survey was a retrospective study and that the positive screen for 
impulse control disorders with QUIP is not comparable to clinical diagnosis. We also 
lack clinical data to confirm self-reported Parkinson’s disease diagnoses. Therefore, the 
results should be interpreted with caution and only as supportive material to the case 
described here. 
Whether the increase in artistic production of our patient is a reflection of increased 
creativity, i.e. something that is novel and meaningful, or merely just an increase in 
basal arousal, can be questioned. Creativity has been defined as the ability to produce 
work that is at the same time novel and meaningful, as opposed to trivial or bizarre 
[13]. The poetry of the patient was accepted twice by a commercial publisher, which 
suggests that the artistic level of his work was above average. From a neurobiological 
and neuropharmacological perspective, one would expect dopamine-enhancing 
therapies to merely increase dopaminergic drive and activation. However, increased 
creative drive can secondarily improve creative skill [14]. First, there can be a practice 
effect: the more the patient paints, writes or acts, the better the quality of his work.  
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Another option is that high motivation increases the number of ideas produced, and 
therefore, a proportional increase in the number of novel and exceptional ideas. 
The patients showed markedly high novelty seeking and impulsiveness, as measured 
with TCI and BIS-11, compared to an earlier report including Parkinson’s disease 
patients with and without impulse control disorders [15]. In addition, the PET imaging 
revealed exceptionally high ventral striatal and left caudate fluorodopa uptake 
suggesting high mesolimbic dopamine function, which has been speculated to be of 
importance in creativity [14] and impulse control disorders [11]. 
The patient had been on a maximal dose of cabergoline for 7 years and had suffered 
from pathological gambling and punding for 5 years before the treatment was stopped 
because of behavioral problems. As the result of the change in treatment, the urges for 
gambling decreased without changes in punding or creativity. There is literature to 
suggest that punding-like repetitive behaviors are particularly associated with 
levodopa treatment [2], whereas impulse control disorders, such as pathological 
gambling, are particularly associated with dopamine agonists [1]. Although one is 
tempted to interpret that, in this case, punding and creativity were related more to 
treatment with levodopa, and pathological gambling more to cabergoline, impulse 
control disorders and punding are known to frequently co-exist and there are multiple 
other factors, apart from medication, that are associated with repetitive behaviors in 
Parkinson’s disease. If deep brain stimulation is performed for this patient in the future, 
a reduction in levodopa dose will be possible, and further behavioral changes could 
emerge. 
The increased risk of impulse control disorders in Parkinson’s disease seems to be 
associated not only with dopaminomimetic medication, but also with several other 
factors, such as younger age, smoking, family history of gambling problems, and 
depression [1, 10, 15]. Here we have described a patient with early-onset Parkinson’s 
disease, who developed an impulse control disorder and punding together with novel 
poetic creativity. The case and our survey add to the cumulative evidence of the 
association between dopaminergic medication and enhanced creativity, and suggest a 
linkage between increased artistic creativity and impulsive-compulsive behaviors in 
Parkinson’s disease. [18F]Fluorodopa PET imaging revealed markedly high mesolimbic 
dopamine function, which could relate to the behavioral changes described here, and is 
suggestive of the overlapping neurobiological mechanism of impulsive-compulsive 
behaviors and creativity. Our preliminary survey of 290 patients further suggests that 
the parallel appearance of these behaviors is not an exceptional rarity in Parkinson’s 
disease. Larger epidemiological and neuroimaging studies are needed to investigate the 
relevance of these findings, with respect to the clinical characteristics and the 
neurobiological background of the phenomenon. 
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Table 1. Changes in the antiparkinsonian medication and the behavior of the patient 
           
Time 
after 
diagnosis 
years 
Medication, daily dose  Non-motor behavioral changes 
           
00  Diagnosis of Parkinson’s disease, selegiline 5 mg  – 
01  Selegiline 5 mg, cabergoline 1 mg  – 
02  Selegiline 5 mg, cabergoline 2 mg  – 
03  Selegiline 5 mg, cabergoline 2 mg, levodopa/carbidopa 100/25 mg  – 
05  Selegiline 10 mg, cabergoline 2 mg, levodopa/carbidopa 200/50 mg  Pathological gambling, punding 
07  Selegiline 10 mg, cabergoline 2 mg, levodopa/carbidopa 200/50 mg  Creativity, pathological gambling, 
punding 
09  PET imaging, selegiline 10 mg, cabergoline 2 mg, levodopa/carbidopa  
300/75 mg 
Creativity, pathological gambling, 
punding 
10  Selegiline 10 mg, pramipexole 0.18 mg, levodopa/carbidopa/entacapone 
750/187.5/1,000 mg 
under consideration for deep brain stimulation 
Creativity, punding 
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